View |
|
DR-XY43246
|
Hyoscine-N-Butylbromide
|
Gastrim
|
20 mg/mL
|
Solution For Injection (Im/Iv/Sc)
|
Anticholinergic Agent
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
01 March 2024
|
03 March 2029
|
View |
|
DR-XY43251
|
Tranexamic acid
|
Nexavell
|
100mg/mL (500mg/5mL)
|
Solution For Injection
|
Antifibrinolytic
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
21 March 2023
|
10 December 2028
|
View |
|
DR-XY43253
|
Lacosamide
|
Vimpat
|
100 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Aesica Pharmaceuticals GmbH
|
Germany
|
Initial (Variation)
|
15 August 2024
|
15 August 2029
|
View |
|
DR-XY43256
|
Rosuvastatin (as Calcium)
|
Lustatin-40
|
40 mg
|
Tablet
|
Antilipidemic
|
SIMPEX PHARMA PVT. LTD.
|
India
|
Renewal
|
09 March 2024
|
28 February 2029
|
View |
|
DR-XY43259
|
Carvedilol
|
Angicarv
|
6.25mg
|
Film Coated Tablet
|
Combined Alpha and Beta - Adrenoreceptor Blocker
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
29 February 2024
|
03 March 2029
|
View |
|
DR-XY43263
|
Prednisolone
|
Neopred
|
5 mg
|
Tablet
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 February 2023
|
26 February 2028
|
View |
|
DR-XY43264
|
Lidocaine Hydrochloride
|
Locaine
|
20 mg/mL (2% w/v)
|
Solution For Injection
|
Local Anesthetic
|
Shreechem Pharmaceuticals Pvt., Ltd
|
India
|
Renewal
|
24 January 2024
|
26 February 2029
|
View |
|
DR-XY43278
|
Amlodipine (as Besilate)
|
Amlodibloc
|
10mg
|
Tablet
|
Calcium Channel Blocker
|
Jiangsu Pengyao Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
19 March 2024
|
07 March 2029
|
View |
|
DR-XY43279
|
Amlodipine (As Besilate)
|
Amlodibloc
|
5mg
|
Tablet
|
Calcium Channel Blocker
|
Jiangsu Pengyao Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal (E-AR)
|
06 March 2024
|
07 March 2029
|
View |
|
DR-XY43283
|
Atracurium Besilate
|
Atravell
|
10mg/mL(50mg/5mL)
|
Solution For Injection (Iv)
|
Neuromuscular Blocking Agent
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
22 December 2023
|
11 March 2029
|
View |
|
DR-XY43285
|
Atracurium Besilate
|
Atravell
|
10mg/mL(25mg/2.5mL)
|
Solution For Injection (Iv)
|
Neuromuscular Blocking Agent
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
16 November 2023
|
11 March 2029
|
View |
|
DR-XY43286
|
Cefuroxime (as Axetil)
|
Bacxime
|
250 mg
|
Film-Coated Tablet
|
Antibacterial (Second Generation Cephalosporin)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
25 March 2024
|
05 March 2029
|
View |
|
DR-XY43295
|
Tramadol Hydrochloride
|
Tramklor
|
50mg
|
Tablet
|
Opioid Analgesics
|
Cspc Ouyi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
31 July 2023
|
18 November 2028
|
View |
|
DR-XY43297
|
Glycerin
|
Glydem
|
626mg/Ml
|
Rectal Solution (Enema)
|
Laxative / Cathartic
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
06 March 2024
|
20 March 2029
|
View |
|
DR-XY43305
|
Tranexamic Acid
|
Hemanex
|
100 mg/mL (500 mg/5 mL)
|
Solution For Injection (IM/IV)
|
Anti-fibrinolytic
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
08 December 2023
|
13 March 2029
|
View |
|
DR-XY43308
|
IRBESARTAN
|
IRBEZIL
|
150mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Aurochem Laboratories
|
India
|
Renewal
|
17 April 2024
|
24 March 2029
|
View |
|
DR-XY43311
|
Phenylephrine Hydrochloride
|
Naldec
|
12.5 mg
|
Syrup
|
Nasal Decongestant
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
24 April 2024
|
17 March 2029
|
View |
|
DR-XY43313
|
Clopidogrel (as bisulfate)
|
Artheogrel
|
75 mg
|
Film Coated Tablet
|
Antithrombotic
|
Bal Pharma Ltd.
|
India
|
Renewal
|
05 February 2024
|
21 April 2029
|
View |
|
DR-XY43317
|
Metformin Hydrochloride
|
Euformin
|
500 mg
|
Film Coated Tablet
|
Oral Hypoglycemic Agent
|
The Acme Laboratories Ltd.
|
Bangladesh
|
Renewal
|
03 December 2023
|
25 March 2029
|
View |
|
DR-XY43320
|
Isopropanolol+benzalkonium Chloride
|
Cutasept F
|
63g/0.025g per 100g
|
Solution
|
Disinfectant /Antiseptic
|
Bode Chemie GmbH
|
Germany
|
Renewal
|
09 March 2024
|
19 March 2029
|